CryptoStar Corp. (CSTR.V)
| Previous Close | 0.1250 |
| Open | 0.1200 |
| Bid | 0.1150 x 0 |
| Ask | 0.1250 x 0 |
| Day's Range | 0.1150 - 0.1250 |
| 52 Week Range | 0.0250 - 0.8400 |
| Volume | 1,443,084 |
| Avg. Volume | 2,607,815 |
| Market Cap | 48.311M |
| Beta (5Y Monthly) | 3.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0380 |
| Earnings Date | Oct. 11, 2021 - Oct. 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Yahoo Finance Video
Blockchain will be ‘hugely disruptive’ to the finance industry: Jenny Johnson
Franklin Templeton President & CEO Jenny Johnson joins 'Influencers with Andy Serwer' to discuss cryptocurrencies, blockchain technology, and their impact on the financial industry.
- CNW Group
CryptoStar Corp. Executes Equipment Hosting Agreement with U.S. Based Customer and Continues Expansion in Alberta, Canada
CryptoStar Corp. (TSXV: CSTR) ("CryptoStar" or the "Company"), a cryptocurrency mining and data centre operator, is pleased to announce that the Company and a U.S. based company (the "Customer") have executed an equipment hosting agreement (the "Hosting Agreement") effective July 14, 2021 for up to 8 MW of mining capacity at its award-winning data centre facility in Utah, USA. The Company is also pleased to announce the expansion of its Hashrate and power capacity in Alberta, Canada.
- GlobeNewswire
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") reports very promising clinical outcomes of the 187 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder (MDD). Treatment outcomes of these 187 patients were very good: 50.3% were in remission at end of treatment a
